Randomized Phase 111 Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endrocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer
Access Status
Fulltext not available
Authors
Wolff, A.
Lazar, A.
Bondarenko, I.
Garin, A.
Brincat, S.
Chow, L.
Sun, Y.
Neskovic-Konstantinovic, Z.
Guimaraes, R.
Fumoleau, P.
Chan, Arlene
Hachemi, S.
Strahs, A.
Cincotta, M.
Berkenblit, A.
Krygowski, M.
Kang, L.L.
Moore, L.
Hayes, D.
Date
2013Type
Journal Article
Metadata
Show full item recordCitation
Wolff, A. and Lazar, A. and Bondarenko, I. and Garin, A. and Brincat, S. and Chow, L. and Sun, Y. et al. 2013. Randomized Phase 111 Placebo-Controlled Trial of Letrozole Plus Oral Temsirolimus As First-Line Endrocrine Therapy in Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer. Journal of Clinical Oncology. 31 (2): pp. 195-202.
Source Title
Journal of Clinical Oncology